UK Markets closed

Pieris Pharmaceuticals, Inc. (PIRS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.7100-0.1800 (-4.63%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close3.8900
Bid3.6800 x 2200
Ask4.8000 x 1800
Day's range3.6850 - 4.0800
52-week range1.7000 - 6.1500
Avg. volume1,242,033
Market cap216.305M
Beta (5Y monthly)1.18
PE ratio (TTM)N/A
EPS (TTM)-0.6900
Earnings date02 Nov 2021 - 08 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est8.50
  • Zacks

    Pieris Pharmaceuticals (PIRS) Reports Q3 Loss, Misses Revenue Estimates

    Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of 0.00% and -49.13%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Motley Fool

    2 Penny Stocks That Could Soar Soon

    Penny stocks, defined as equities with share prices under $5, are ultra-risky investing vehicles. Companies with super-low share prices are often in financial peril, have a bad habit of excessively diluting shareholders, or (more plainly) their products simply don't sell very well. Healthcare penny stocks, however, can fall under a completely different umbrella than the typical low-priced equity.

  • Motley Fool

    2 Stocks I Bought Last Week

    One is a small-cap that's using the franchise model with chiropractors, and one is a tiny biotech that just might be the biggest stock of 2022.